TELDRIN Trademark

Trademark Overview


On Thursday, October 2, 2014, a trademark application was filed for TELDRIN with the United States Patent and Trademark Office. The USPTO has given the TELDRIN trademark a serial number of 86413203. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 17, 2025. This trademark is owned by Gemini Pharmaceuticals, Inc.. The TELDRIN trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines
teldrin

General Information


Serial Number86413203
Word MarkTELDRIN
Filing DateThursday, October 2, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 17, 2025
Registration Number4716483
Registration DateTuesday, April 7, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2015

Trademark Statements


Goods and ServicesAntihistamines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 17, 2025
Primary Code005
First Use Anywhere DateThursday, March 26, 1953
First Use In Commerce DateThursday, March 26, 1953

Trademark Owner History


Party NameGemini Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCommack, NY 11725

Party NameGemini Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCommack, NY 11725

Party NameGemini Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCommack, NY 11725

Trademark Events


Event DateEvent Description
Monday, October 6, 2014NEW APPLICATION ENTERED
Thursday, October 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 4, 2014ASSIGNED TO EXAMINER
Friday, December 5, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 31, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 20, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 14, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 11, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 14, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 19, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, August 10, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 10, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 10, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, April 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, October 17, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords


teldrin antihistamines